{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Investigational
Source:
NCT04086472: Phase 2 Interventional Completed Respiratory Syncytial Viruses
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02696902: Phase 2 Interventional Completed Pseudomonas Aeruginosa
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01342263: Not Applicable Interventional Completed Ischemic Heart Disease
(2011)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zilovertamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
NCT02655510: Phase 1/Phase 2 Interventional Completed Alcoholic Hepatitis
(2016)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03733314: Phase 2 Interventional Completed Crohn's Disease
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:rademikibart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT04022213: Phase 2 Interventional Recruiting Desmoplastic Small Round Cell Tumor
(2019)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03516591: Phase 1 Interventional Completed Myelodysplastic Syndrome (MDS)
(2018)
Source URL:
Class:
PROTEIN
